跳至主要内容
临床试验/NCT02294032
NCT02294032已完成不适用

The Role of B Cells in Kidney Allograft Dysfunction

Loma Linda University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2014年8月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
1
主要终点
Blood collection prior to and after kidney transplantation

研究概览

简要总结

The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune response after kidney transplantation. In this study, blood will be collected from kidney transplant patients during different timepoints, prior to and after their transplant. Knowledge gained from study findings will be used to develop therapeutic strategies to prevent antibody-mediated rejection, which is a major cause of long-term graft loss in kidney transplant patients.

详细描述

The purpose of this study is to understand the role of specific B cells in activating or repressing an anti-allograft immune responses after kidney transplantation. This study aims to address two major challenges in kidney transplantation: 1. to guide physicians when immunosuppressive drugs are weaned, and 2. to identify patients who are at risk or in the process of developing antibody-mediated rejection. In this study, blood will be collected from kidney transplant patients during different timepoints, prior to and after their transplant. Knowledge gained from study findings will be used to develop therapeutic strategies to prevent antibody-mediated rejection, which is a major cause of long-term graft loss in kidney transplant patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
2 Years 至 85 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to understand and willingness to sign the written informed consent form (ICF). For pediatric patients, a parent or legal guardian must sign ICF
  • Either a Kidney or Liver transplant patient: 1) on the waitlist or 2) transplanted
  • Healthy volunteer samples collected to use as the control group for statistical validity

排除标准

  • Inability to make all of the required long-term post-transplant visits.
  • Females who are pregnant or nursing a child
  • Liver patients with hepatitis C virus

研究组 & 干预措施

Kidney Transplant

Patients who are about to undergo a kidney transplant and are on immunosuppressive agents.

干预措施: Immunosuppressive Agents (Drug)

结局指标

主要结局

Blood collection prior to and after kidney transplantation

时间窗: 1,3,6,12,18,24,36,48, and 60 months

Blood will be collected from kidney transplant patients prior to and after their transplant (1-, 3-, 6-, 12-, 18-, 24-, 36-, 48-, and 60- months post-transplant). We will try to better understand the role of specific B-cells after kidney transplant by using enzyme-linked immunosorbent assay (ELISA).

次要结局

  • B cell count(Up to 60 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验